Amundi
TGTX icon

Amundi’s TG Therapeutics TGTX Stock Holding History

Amundi’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$460K Buy
+13,845
New +$413K ﹤0.01% 1575
2023
Q1 		– Sell
-11,009
Closed -$144K – 2123
2022
Q4 		$144K Sell
11,009
-1,585
-13% -$11.5K ﹤0.01% 1559
2022
Q3 		$79K Buy
+12,594
New +$82.6K ﹤0.01% 1595
2022
Q2 		– Sell
-5,726
Closed -$56K – 1716
2022
Q1 		$56K Hold
5,726
– – ﹤0.01% 1527
2021
Q4 		$88K Hold
5,726
– – ﹤0.01% 1583
2021
Q3 		$191K Hold
5,726
– – ﹤0.01% 1445
2021
Q2 		$222K Buy
+5,726
New +$225K ﹤0.01% 1362

Other funds holding TGTX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return